These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29615905)

  • 1. Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program.
    Soler J; Elices M; Dominguez-Clavé E; Pascual JC; Feilding A; Navarro-Gil M; García-Campayo J; Riba J
    Front Pharmacol; 2018; 9():224. PubMed ID: 29615905
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.
    Soler J; Elices M; Franquesa A; Barker S; Friedlander P; Feilding A; Pascual JC; Riba J
    Psychopharmacology (Berl); 2016 Mar; 233(5):823-9. PubMed ID: 26612618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits.
    Domínguez-Clavé E; Soler J; Pascual JC; Elices M; Franquesa A; Valle M; Alvarez E; Riba J
    Psychopharmacology (Berl); 2019 Feb; 236(2):573-580. PubMed ID: 30406413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Four Weekly Ayahuasca Sessions Lead to Increases in "Acceptance" Capacities: A Comparison Study with a Standard 8-Week Mindfulness Training Program.
    Soler J; Elices M; Dominguez-Clavé E; Pascual JC; Feilding A; Navarro-Gil M; Garcia-Campayo J; Riba J
    Front Pharmacol; 2020; 11():635111. PubMed ID: 33551823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between meditative practice and self-reported mindfulness: the MINDSENS composite index.
    Soler J; Cebolla A; Feliu-Soler A; Demarzo MM; Pascual JC; Baños R; García-Campayo J
    PLoS One; 2014; 9(1):e86622. PubMed ID: 24466175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
    Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
    Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.
    Meling D; Egger K; Aicher HD; Jareño Redondo J; Mueller J; Dornbierer J; Temperli E; Vasella EA; Caflisch L; Pfeiffer DJ; Schlomberg JT; Smallridge JW; Dornbierer DA; Scheidegger M
    J Psychopharmacol; 2024 Oct; 38(10):897-910. PubMed ID: 39340164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers.
    Murphy-Beiner A; Soar K
    Psychopharmacology (Berl); 2020 Apr; 237(4):1161-1169. PubMed ID: 31927605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
    Sampedro F; de la Fuente Revenga M; Valle M; Roberto N; Domínguez-Clavé E; Elices M; Luna LE; Crippa JAS; Hallak JEC; de Araujo DB; Friedlander P; Barker SA; Álvarez E; Soler J; Pascual JC; Feilding A; Riba J
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):698-711. PubMed ID: 28525587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomised trial comparing a mindfulness-based stress reduction course, a locally-developed stress reduction intervention and a waiting list control group in a real-life municipal health care setting.
    Juul L; Pallesen KJ; Bjerggaard M; Nielsen C; Fjorback LO
    BMC Public Health; 2020 Mar; 20(1):409. PubMed ID: 32228533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
    Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.
    Eleftheriou ME; Thomas E
    Front Psychiatry; 2021; 12():707057. PubMed ID: 34456763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ayahuasca may help to improve self-compassion and self-criticism capacities.
    Domínguez-Clavé E; Soler J; Elices M; Franquesa A; Álvarez E; Pascual JC
    Hum Psychopharmacol; 2022 Jan; 37(1):e2807. PubMed ID: 34411343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
    Aicher HD; Mueller MJ; Dornbierer DA; Suay D; Elsner C; Wicki I; Meling D; Caflisch L; Hempe A; Steinhart C; Mueller J; Von Rotz R; Kleim B; Scheidegger M
    Front Psychiatry; 2023; 14():1302559. PubMed ID: 38264636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ayahuasca and the traveller: A scoping review of risks and possible benefits.
    Houle SKD; Evans D; Carter CA; Schlagenhauf P
    Travel Med Infect Dis; 2021; 44():102206. PubMed ID: 34785376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness and bodily distress.
    Fjorback LO
    Dan Med J; 2012 Nov; 59(11):B4547. PubMed ID: 23171754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Five Facet Mindfulness Questionnaire measure what we think it does? Construct validity evidence from an active controlled randomized clinical trial.
    Goldberg SB; Wielgosz J; Dahl C; Schuyler B; MacCoon DS; Rosenkranz M; Lutz A; Sebranek CA; Davidson RJ
    Psychol Assess; 2016 Aug; 28(8):1009-14. PubMed ID: 26460893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study protocol for a cluster randomised controlled trial on mindfulness-based stress reduction: studying effects of mindfulness-based stress reduction and an additional organisational health intervention on mental health and work-related perceptions of teachers in Dutch secondary vocational schools.
    Janssen M; Heerkens Y; Van der Heijden B; Korzilius H; Peters P; Engels J
    Trials; 2020 May; 21(1):376. PubMed ID: 32366329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.